Clinical Trial Update: BIO-CHECKPOINT 0 Biomarkers to Identify Oncology Patients on ICPI at Greater Risk of irAE

View source ↗

Summary

A completed clinical trial (BIO-CHECKPOINT 0) evaluated biomarkers to identify cancer patients on immune checkpoint inhibitors who are at greater risk of immune…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Portsmouth Hospitals NHS Trust | Conditions: Neoplasms | Status: COMPLETED